Hologic, Inc. (0J5Q.L)
USD 57.45
(1.41%)
USD 57.45
(1.41%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 | 1.29 Billion USD | 16.71% |
| 2023 | 1.11 Billion USD | -38.33% |
| 2022 | 2.07 Billion USD | -28.08% |
| 2021 | 2.88 Billion USD | 89.31% |
| 2020 | 1.52 Billion USD | 48.03% |
| 2019 | 1.03 Billion USD | 4.34% |
| 2018 | 988.3 Million USD | 3.83% |
| 2017 | 1.83 Billion USD | -7.1% |
| 2016 | 1.03 Billion USD | 5.08% |
| 2015 | 975 Million USD | 9.76% |
| 2014 | 888.3 Million USD | 4.64% |
| 2013 | -395.87 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 315.1 Million USD | 11.9% |
| 2024 Q2 | 317 Million USD | 0.6% |
| 2024 Q3 | 329 Million USD | 3.79% |
| 2024 Q4 | 328.1 Million USD | -0.27% |
| 2023 FY | - USD | -39.16% |
| 2023 Q2 | 342.3 Million USD | -2.03% |
| 2023 Q1 | 349.4 Million USD | 22.6% |
| 2023 Q4 | 264.3 Million USD | -14.3% |
| 2023 Q3 | 308.4 Million USD | -9.9% |
| 2022 Q1 | 745.4 Million USD | 32.3% |
| 2022 FY | - USD | -28.08% |
| 2022 Q4 | 285 Million USD | -15.85% |
| 2022 Q3 | 338.7 Million USD | -51.62% |
| 2022 Q2 | 700.1 Million USD | -6.08% |
| 2021 FY | - USD | 89.31% |
| 2021 Q3 | 463.4 Million USD | -47.28% |
| 2021 Q4 | 563.4 Million USD | 21.58% |
| 2021 Q1 | 984.3 Million USD | 32.25% |
| 2021 Q2 | 878.9 Million USD | -10.71% |
| 2020 Q3 | 285.6 Million USD | 13.11% |
| 2020 Q4 | 744.3 Million USD | 160.61% |
| 2020 FY | - USD | 48.03% |
| 2020 Q1 | 251.2 Million USD | -9.05% |
| 2020 Q2 | 252.5 Million USD | 0.52% |
| 2019 FY | - USD | 4.34% |
| 2019 Q4 | 276.2 Million USD | 5.7% |
| 2019 Q3 | 261.3 Million USD | 4.39% |
| 2019 Q1 | 262.8 Million USD | 4.74% |
| 2019 Q2 | 250.3 Million USD | -4.76% |
| 2018 Q2 | 248.8 Million USD | -3.98% |
| 2018 Q3 | 259.39 Million USD | 4.26% |
| 2018 Q4 | 250.9 Million USD | -3.28% |
| 2018 FY | - USD | 3.83% |
| 2018 Q1 | 259.1 Million USD | -3.97% |
| 2017 Q2 | 218.6 Million USD | -17.35% |
| 2017 FY | - USD | -7.1% |
| 2017 Q3 | 258.89 Million USD | 18.44% |
| 2017 Q1 | 264.5 Million USD | -0.04% |
| 2017 Q4 | 269.8 Million USD | 4.21% |
| 2016 Q4 | 264.6 Million USD | 1.07% |
| 2016 Q1 | 250.3 Million USD | -1.69% |
| 2016 Q2 | 253.9 Million USD | 1.44% |
| 2016 Q3 | 261.8 Million USD | 3.11% |
| 2016 FY | - USD | 5.08% |
| 2015 Q4 | 254.6 Million USD | 2.5% |
| 2015 FY | - USD | 9.76% |
| 2015 Q2 | 238.4 Million USD | 2.1% |
| 2015 Q1 | 233.5 Million USD | -4.15% |
| 2015 Q3 | 248.4 Million USD | 4.19% |
| 2014 Q1 | 207.4 Million USD | -5.94% |
| 2014 FY | - USD | 4.64% |
| 2014 Q3 | 216.8 Million USD | -1.0% |
| 2014 Q2 | 219 Million USD | 5.59% |
| 2014 Q4 | 243.6 Million USD | 12.36% |
| 2013 Q1 | 210.83 Million USD | 0.0% |
| 2013 Q4 | 220.5 Million USD | -0.03% |
| 2013 Q3 | 220.56 Million USD | 11.98% |
| 2013 Q2 | 196.96 Million USD | -6.58% |
| 2013 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Phreesia, Inc. | -102.94 Million USD | 1359.119% |
| Accuray Incorporated | 9 Million USD | -14287.834% |
| Align Technology, Inc. | 799.03 Million USD | -62.22% |
| Elevance Health Inc. | 10.49 Billion USD | 87.643% |
| AxoGen, Inc. | -13.32 Million USD | 9825.39% |
| Boston Scientific Corporation | 3.61 Billion USD | 64.124% |
| CVS Health Corporation | 18.17 Billion USD | 92.869% |
| Cardinal Health, Inc. | 1.97 Billion USD | 34.469% |
| Centene Corporation | -463 Million USD | 379.957% |
| DaVita Inc. | 2.34 Billion USD | 44.759% |
| HCA Healthcare, Inc. | 12.72 Billion USD | 89.811% |
| Humana Inc. | -561 Million USD | 331.052% |
| IDEXX Laboratories, Inc. | 1.21 Billion USD | -6.45% |
| Laboratory Corporation of America Holdings | 1.34 Billion USD | 3.942% |
| Masimo Corporation | 236.7 Million USD | -447.613% |
| McKesson Corporation | 4.66 Billion USD | 72.226% |
| Patterson Companies, Inc. | 374.75 Million USD | -245.878% |
| Quest Diagnostics Incorporated | 1.73 Billion USD | 25.162% |
| ResMed Inc. | 1.6 Billion USD | 19.004% |
| Henry Schein, Inc. | 943 Million USD | -37.455% |
| Teladoc Health, Inc. | 153.99 Million USD | -741.705% |
| Universal Health Services, Inc. | 1.74 Billion USD | 25.652% |
| Veeva Systems Inc. | 429.33 Million USD | -201.909% |
| Baxter International Inc. | 2.77 Billion USD | 53.307% |
| Becton, Dickinson and Company | 4.27 Billion USD | 69.68% |
| Intuitive Surgical, Inc. | 2.39 Billion USD | 45.859% |
| Danaher Corporation | 7.49 Billion USD | 82.715% |
| Stryker Corporation | 5.16 Billion USD | 74.88% |
| Medtronic plc | 9.05 Billion USD | 85.687% |